233 related articles for article (PubMed ID: 27164362)
1. Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.
He J; Pan Z; Tian G; Liu X; Liu Y; Guo X; An Y; Song L; Wu H; Cao H; Yu D; Che R; Xu P; Rasoul LM; Li D; Yin J
Virus Res; 2016 Aug; 221():23-9. PubMed ID: 27164362
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of Newcastle disease virus with derivated hemagglutinin-neuraminidase gene of mesogenic strain].
Wang Y; Ge J; Ding Y; Xie X; Bu Z
Wei Sheng Wu Xue Bao; 2008 May; 48(5):638-43. PubMed ID: 18652296
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone.
Estevez C; King D; Seal B; Yu Q
Virus Res; 2007 Nov; 129(2):182-90. PubMed ID: 17719672
[TBL] [Abstract][Full Text] [Related]
4. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells
Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.
He D; Sun L; Li C; Hu N; Sheng Y; Chen Z; Li X; Chi B; Jin N
Viruses; 2014 Feb; 6(2):856-74. PubMed ID: 24553109
[TBL] [Abstract][Full Text] [Related]
6. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy.
Wu Y; He J; Geng J; An Y; Ye X; Yan S; Yu Q; Yin J; Zhang Z; Li D
Eur J Pharmacol; 2017 May; 802():85-92. PubMed ID: 28246027
[TBL] [Abstract][Full Text] [Related]
8. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.
Huang Z; Panda A; Elankumaran S; Govindarajan D; Rockemann DD; Samal SK
J Virol; 2004 Apr; 78(8):4176-84. PubMed ID: 15047833
[TBL] [Abstract][Full Text] [Related]
9. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
[TBL] [Abstract][Full Text] [Related]
10. The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect.
Jung BK; An YH; Jang SH; Jang JJ; Kim S; Jeon JH; Kim J; Song JJ; Jang H
Virol J; 2024 Jan; 21(1):7. PubMed ID: 38178138
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model.
An Y; Liu T; He J; Wu H; Chen R; Liu Y; Wu Y; Bai Y; Guo X; Zheng Q; Liu C; Yin J; Li D; Ren G
J Biomed Sci; 2016 Jul; 23(1):55. PubMed ID: 27465066
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice.
Wei D; Li Q; Wang XL; Wang Y; Xu J; Feng F; Nan G; Wang B; Li C; Guo T; Chen ZN; Bian H
J Exp Clin Cancer Res; 2015 Dec; 34():153. PubMed ID: 26689432
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.
Ren G; Tian G; Liu Y; He J; Gao X; Yu Y; Liu X; Zhang X; Sun T; Liu S; Yin J; Li D
Technol Cancer Res Treat; 2016 Oct; 15(5):NP83-94. PubMed ID: 26303327
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240.
Ghrici M; El Zowalaty M; Omar AR; Ideris A
Oncol Rep; 2013 Sep; 30(3):1035-44. PubMed ID: 23807159
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of anti-tumor activity of Newcastle disease virus by the synergistic effect of cytosine deaminase.
Lv Z; Zhang TY; Yin JC; Wang H; Sun T; Chen LQ; Bai FL; Wu W; Ren GP; Li DS
Asian Pac J Cancer Prev; 2013; 14(12):7489-96. PubMed ID: 24460323
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy.
Wu Y; He J; An Y; Wang X; Liu Y; Yan S; Ye X; Qi J; Zhu S; Yu Q; Yin J; Li D; Wang W
J Pharmacol Sci; 2016 Sep; 132(1):24-30. PubMed ID: 27174862
[TBL] [Abstract][Full Text] [Related]
17. Effects of the HN gene C-terminal extensions on the Newcastle disease virus virulence.
Zhao W; Zhang Z; Zsak L; Yu Q
Virus Genes; 2013 Dec; 47(3):498-504. PubMed ID: 24037042
[TBL] [Abstract][Full Text] [Related]
18. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.
Buijs P; van Nieuwkoop S; Vaes V; Fouchier R; van Eijck C; van den Hoogen B
Viruses; 2015 Jun; 7(6):2980-98. PubMed ID: 26110582
[TBL] [Abstract][Full Text] [Related]
20. C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4.
Ren X; Zeng Z; Shang Y; Yao L; Li L; Zhang W; Guo Y; Wang H; Zhang R; Shao H; Hu S; Luo Q; Wen G
Arch Virol; 2023 Jul; 168(8):203. PubMed ID: 37418014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
